Vita Medical Products (Guangzhou) Co., Ltd. received approval for phase II of its blood purification product R&D and production base in Zengcheng, Guangzhou, with a total investment of 400 million yuan and expected annual output value of 500 million yuan.

Ypsomed held the groundbreaking for a new production facility in the Changzhou National Hi-tech District on 25 April 2023, investing over CHF 35 million in a first phase. Production is expected to start in the second half of 2024.

Lianying Medical, parent of the MDKMed brand, has completed the full acquisition of Zhejiang Smith Medical Instruments and the Graseby infusion pump brand from U.S. company ICU Medical. The announcement was made on 10 January 2023; no deal value is stated.

Lincotek Medical is investing in its Wuxi, Jiangsu manufacturing centre by doubling coating capacity for orthopaedic implants with a second CAPS Intercooler and adding a cleaning and packaging line.

Cochlear Limited announced plans for a new manufacturing facility in Chengdu, Sichuan province, China, for cochlear implants and sound processors, with an estimated investment of AUD 50 million. Production is expected to start within four years, subject to approvals.